Last reviewed · How we verify
Nicotine Oral Pouch
At a glance
| Generic name | Nicotine Oral Pouch |
|---|---|
| Also known as | ZYN, Rogue, On!, Fre |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction (NA)
- Nordic Spirit Pouch Nicotine Pharmacokinetics Abuse Liability (PHASE1)
- A Relative Bioavailability Study of Nicotine Delivery From Selected Oral Nicotine Products (NA)
- Studying the Health Perceptions and Social Behaviors of Graduate Students at the Ohio State University for the Development of Effective Oral Nicotine Pouch Addictive Risk Communication (NA)
- Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches (NA)
- Acute Effects of Oral Nicotine Pouches (PHASE1)
- Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior (NA)
- Oral Nicotine Pouch Marketing Features Influence on Perceptions (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nicotine Oral Pouch CI brief — competitive landscape report
- Nicotine Oral Pouch updates RSS · CI watch RSS
- Ohio State University Comprehensive Cancer Center portfolio CI